NRXP NRX Pharmaceuticals Inc

$NRXP The shorts were betting on dilution. They were caught off guard by the DARPA funding. There is a 27% short float, 17 days to cover, and a 90% chance of FDA approval before November 10th. That could work out well.

$NRXP There is no better example of how a government bureaucracy messes everything up, than how the FDA is handling Ketafree. All they have to do look at a signature on a piece of paper. "Sorry guys, thats gonna take us until November 20 to do that. It's our rules". Lol. Sure it can happen before that date, and likely will. Those should have and could have easily of been handled within a week. But thats the government for you.

$NRXP "The Company believes that these data will be consistent with a labeled shelf life of three years or longer" (today's PR).

$NRXP Well, I had to pick up another 5K shares . I’m down quite a bit — around $30K in the red — but I’ve been in this play for a long time. I was here back in the Spac era and managed to make a buck along the way. Still holding on and hoping this story delivers. Come on, JJ, don’t let us down this time! Let’s finally see some real results and reward the long-term shareholders who’ve stuck around through it all. 💎🙌

$NRXP With current news shorts are absolutely forced to cover.....expect a slow and steady raise from now until Nov. 9th and then a 🚀 on Nov. 10th

$NRXP Loaded another 5K shares. Appreciate the discount! Everything from here on out is a bargain. Wish I could load up more, but my boat is already fully loaded with 55k shares. Holding period: 24–36 months. Let's see how this one plays out.

$NRXP Just opened a position! 🚀 FDA decision approaching on Nov 10. Bullish on the potential! 🔥

$NRXP …. as someone who has had both repetitive TMS & IV ketamine therapy, I can tell you this is a significant development. Being able to precisely target the area of the brain in need of repair and to also be able to quantify outcomes is incredible! AND, to be able to accomplish this with less visits…even better!

$NRXP ✈️ Plane is working hard to move clinical treatment teams around on a weekend, at midnight, and to Louisana where SPARC-TMS has a location. Oh wait... They have none there? They are not even recruiting yet? Hmmm🤔 The medical team also got to take a sightseeing flight on Sunday. Niiice. Who at this company actually checks to make sure the aircraft is being handled responsibly on behalf of the shareholders? Is anyone in BoD interested in this? Sharehodlers don't even know yet whether private flights are authorized and whether the company is compensated for them. Ever since the plane suddenly appeared as an asset in the 10-Q, there has still been no clear explanation of what it is used for. Only the CEO writes on a social media platform that the plane "will be used under a government contract to move a clinical treatment team from one location to another". The activity log does not indicate that!

$NRXP NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

$NRXP Jonny, as you know well, we had nothing to do with the actions of Big Rock Partners pre-merger as evidenced from my being released from the litigation with no settlement whatsoever. Your statement that Javitt owes BRPA investors miney is libelous.

$NRXP this is getting silly. Unless they are completely lying about only have a minor issue to fix then they will get FDA approval within the next month or so.

$NRXP The $11.18M DARPA contract is more important than the dollar amount alone. It provides non-dilutive funding for the FDA-cleared SPARC-TMS Phase 2/3 program and potentially expands NRX-101 from bipolar depression into the much larger treatment-resistant depression market. Combined with the upcoming KETAFREE decision, NRXP is becoming increasingly de-risked without having to finance every development step through dilution.

$NRXP today’s news is great for shareholders (potentially) 2-3 years down the road. What we need is news that helps shareholders that have been holding the bags for 5+ years: Ketafree/nrx-100.

$NRXP Adding a few more. Seems like everything these days are trading on algos. No news in my opinion is making people nervous that they will never get fda approval. Look at the reality. They only have a minor issue. Things will be better in the coming months.

$NRXP Which retards are selling at this price? ANDA approval is within 2 months now. I don't understand the weird actions of the people selling down here. 🚀

$NRXP FDA does an important job, but efficiency is not one of them. WebProFab, Medisca, NBGS...all offer a FDA compliant/registered leur lock syringe bottles. Nephron who is the manufacturer for NRXP received approval in Dec. 2020. Someone just wanted to show who's in control... Approval soon? I think so. Cheers-

$NRXP big week for long shareholders. Should have confirmation of 3 year realtime stability on NRX-100 and Ketafree.

$NRXP Why on earth does FDA parasites need 3 months full to verify the attestation from August? If these guys were less useless the company would have been able to generate cash from August already.

$NRXP Lot of people questioning their investment here as the price languishes to FDA decision. Just some aprox. numbers. Ketamine market value for 2025 is about 4 billion projected to reach 7 billion plus by 2031. Now, the patent they secured for preservative free ketamine is good till 2045. So, if they get approval, which the fda is not flagging any issues besides the leur lock, why would you want to inject your patients with preservatives opening the door for adverse reactions which some patients have had. What if they are able to garner, lets say 10% of the market. That would be aprox.$400 million? Yeah, we don't have that approval yet but if NRXP gets that stamp, it should see some major repricing. Do they open up the ATM? To be expected, this is a small bio. I just don't think the raise will be at these share prices. Just some thoughts as we all wait. Cheers-